Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:SUPG
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio: N/A
- P/E Growth: N/A
Frequently Asked Questions for Astex Pharmaceuticals (NASDAQ:SUPG)
What is Astex Pharmaceuticals' stock symbol?
Astex Pharmaceuticals trades on the NASDAQ under the ticker symbol "SUPG."
Who are some of Astex Pharmaceuticals' key competitors?
Some companies that are related to Astex Pharmaceuticals include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), Catalent (CTLT), NMC Health PLC (NMC), VWR Corp (VWR), Cotiviti Holdings (COTV), Puma Biotechnology (PBYI) and Hikma Pharmaceuticals Plc (HIK).
How do I buy Astex Pharmaceuticals stock?
Shares of Astex Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Astex Pharmaceuticals' stock price today?
MarketBeat Community Rating for Astex Pharmaceuticals (NASDAQ SUPG)MarketBeat's community ratings are surveys of what our community members think about Astex Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Astex Pharmaceuticals stock can currently be purchased for approximately $2.03.
Consensus Ratings for Astex Pharmaceuticals (NASDAQ:SUPG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Astex Pharmaceuticals (NASDAQ:SUPG)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Astex Pharmaceuticals (NASDAQ:SUPG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Astex Pharmaceuticals (NASDAQ:SUPG)
Current Year EPS Consensus Estimate: $0.17 EPS
Dividend History for Astex Pharmaceuticals (NASDAQ:SUPG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Astex Pharmaceuticals (NASDAQ:SUPG)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Astex Pharmaceuticals (NASDAQ:SUPG)
Latest Headlines for Astex Pharmaceuticals (NASDAQ:SUPG)
Astex Pharmaceuticals (SUPG) Chart for Tuesday, July, 25, 2017